Lung Cancer > International Congress for Lung Cancer - New York

International Lung Cancer Congress

Agenda

International Congress for Lung Cancer October 3-4, 2008
7:00 AM	Continental Breakfast and Registrations
7:55 AM	Welcome and Introductions	Chandra P. Belani, MD
Keynote Lectures Session Chair: Chandra P. Belani, MD
8:00 AM	Screening for Lung Cancer: An Overview	Edward Patz, MD
8:30 AM	Locally Advanced Non?Small-Cell Lung Cancer: Implications of SWOG 9504, S0023, and the HOG Studies	Walter Curran, MD
9:00 AM	Adjuvant Therapy of NSCLC: Consensus/ Controversies and Staging Disease	Harvey Pass, MD

EGFR and VEGF Targeted Agents Session Chair: Suresh Ramalingam, MD

9:30 AM	Erlotinib: Present Status and Future Perspectives, Molecular Markers and Patient Selection	Roman-Perez Soler, MD
10:00 AM	Panel Discussion
10:15 AM	Break
10:30 AM	Advanced and Metastatic Non?Small-Cell Lung Cancer: Implications of Bevacizumab	Ronald Natale, MD
11:00 AM	Other VEGF Targeted Agents and Multikinase Inhibitors in the Treatment of Lung Cancer	Suresh Ramalingam, MD

11:30 AM	Panel Discussion
11:45 AM	Lunch
International Forum on Cooperative Groups
12:45 PM	ECOG	Chandra P. Belani, MD
1:15 PM	SWOG	Ronald Natale, MD
1:45 PM	RTOG	Walter Curran, MD
2:15 PM	CALGB	Ramaswamy Govindan, MD
3:45 PM	Panel Discussion
3:00 PM	Closing Remarks and Adjourn	Chandra P. Belani, MD
Saturday - October 4, 2008
7:00 AM	Continental Breakfast
7:55 AM	Welcome and Introductions	Chandra P. Belani, MD
Lung Cancer: State of the Art Session Chair: Ronald Natale, MD
8:00 AM	Non-Small cell lung cancer: State of the Art and Histology Interactions	Ramaswamy Govindan, MD
8:30 AM	Small?Cell Lung Cancer: Novel Agents and Recent Advances	Ronald Natale, MD
9:00 AM	Non?Small-Cell Lung Cancer: Second Line Therapy and Special Populations	Corey Langer, MD
9:30 AM	Women and Lung Cancer	Suresh Ramalingam, MD
10:00 AM	Panel Discussion
10:15 AM	Brack
Emerging Novel Agents and Supportive Care Issues Session Chair : Fadlo Khuri, MD
10:30 AM	Supportive Care Issues in Lung Cancer	Jeffrey Crawford, MD
11:00 AM	Novel Agents: nab-Paclitaxel, Bortezomib and HDAC Inhibitors	Chandra Belani, MD
11:30 AM	Emerging Novel Agents in Lung Cancer TRAIL and mTOR Inhibitors, MEK Inhibitors, AKT Inhibitors and IGF-IR Antibodies and small molecules, c-met Inhibitors	Fadlo Khuri, MD

12:00 PM	Panel Discussion
12:15 PM	Closing Remarks and Adjourn	Chandra P. Belani, MD

International Lung Cancer Congress

Agenda

International Cancer Network, serving internationally